NDC 17856-1133-2 - SPIRONOLACTONE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1133
- Requested NDC
- 17856-1133-2
- Package NDCs from labels
- 17856-1133-3, 17856-1133-1, 17856-1133-2, 17856-1133-4, 17856-1133-5, 17856-1133-6, 17856-1133-7, 17856-1133-8
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-08-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SPIRONOLACTONE - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-08-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1133-1 | SPIRONOLACTONE | 2.5 mL in 1 SYRINGE | SUSPENSION | 2.5 | 6 | |
| 17856-1133-1 | SPIRONOLACTONE | 1 in 1 BAG | SUSPENSION | 1 | 6 | |
| 17856-1133-4 | SPIRONOLACTONE | 2.5 mL in 1 SYRINGE | SUSPENSION | 2.5 | 6 | |
| 17856-1133-4 | SPIRONOLACTONE | 1 in 1 BAG | SUSPENSION | 1 | 6 | |
| 17856-1133-5 | SPIRONOLACTONE | 1 mL in 1 SYRINGE | SUSPENSION | 1 | 6 | |
| 17856-1133-5 | SPIRONOLACTONE | 120 in 1 CASE | SUSPENSION | 120 | 6 | |
| 17856-1133-6 | SPIRONOLACTONE | 3 mL in 1 SYRINGE | SUSPENSION | 3 | 6 | |
| 17856-1133-6 | SPIRONOLACTONE | 120 in 1 CASE | SUSPENSION | 120 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1133 | SPIRONOLACTONE SUSPENSION [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, 8 package rows | 20240605_122558a0-57bb-4195-9adf-d37b049cbfb5.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loperamide Hydrochloride and Simethicone | LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE | Camber Consumer Care Inc | e2a4af66-1d05-408c-9f11-f2a9f325d75c | 2022-09-12 | Warnings | 92RU3N3Y1O |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | PDC6A3C0OX |
| Loperamide HCl and Simethicone | LOPERAMIDE HCL AND SIMETHICONE | Ohm Laboratories Inc. | 06f99f59-e702-49f1-bb1d-e7cf58c54c30 | 2022-08-30 | Warnings | 92RU3N3Y1O |
| Glycerinum | GLYCERINUM | Hahnemann Laboratories, INC. | e34f8796-85b5-2946-e053-2995a90a251e | 2022-07-08 | PDC6A3C0OX | |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | f42ac50f-0ec5-4713-a4c8-99d972d90bed | 2022-06-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | e71c6c83-d518-496c-b2ab-efd5987e4783 | 2022-06-09 | Warnings, Adverse reactions | 059QF0KO0R |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | XF417D3PSL B22547B95K | |
| Miracle FootCream Lavender | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db520c80-2a2a-5eb1-e053-2995a90a5bb4 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Miracle FootCream Lemon | UREA, GLYCERIN, ALOE, DISODIUM EDTA | Aloe Vera Korea Co.,Ltd. | db525c63-29fd-2033-e053-2995a90a56b9 | 2022-03-28 | Warnings | PDC6A3C0OX |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | a63da38d-1fea-4ee0-a70b-55c891a5ebcc | 2022-02-11 | B22547B95K | |
| Sodium Citrate Blood-Pack Units, (PL 146 Plastic) | ANTICOAGULANT SODIUM CITRATE SOLUTION | Fenwal, Inc. | ac8971a9-36d0-43c9-9121-ba5e58c28bed | 2022-02-11 | B22547B95K | |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | XF417D3PSL | |
| Sterile Water | WATER | American Regent, Inc. | 78b35864-4bbc-4759-a5c1-7e4f25e22932 | 2022-01-31 | Boxed warning | 059QF0KO0R |
| Sterile Diluent for Treprostinil | WATER | Dr.Reddy's Laboratories Inc., | 33050ee2-519b-1f0b-d4df-9e14dd329c57 | 2021-12-23 | Warnings, Adverse reactions | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | d763511e-f1a7-4014-94b9-f7ad8f023ff4 | 2021-12-02 | XF417D3PSL B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | cf9f43a0-c750-4cf0-ac49-176ab2105aab | 2021-12-02 | XF417D3PSL B22547B95K | |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | e4f06c0b-7cb1-49c9-97a4-2cfc21298495 | 2021-11-16 | Warnings, Adverse reactions | B22547B95K |
| Spironolactone | SPIRONOLACTONE | Aphena Pharma Solutions - Tennessee, LLC | 1c97ce61-8e49-4724-a636-d179479d346c | 2021-10-14 | Boxed warning, Warnings, Adverse reactions | 27O7W4T232 |
| Solucion InterSol | SOLUCION ADITIVA PARA PLAQUETAS 3 | Fenwal, Inc. | d5eaf5f4-67d3-4475-af9a-f5b0f882f5d1 | 2021-10-04 | Warnings, Adverse reactions | B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.